You Lu

Sichuan University

H指数:12

被引数:751

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Low-dose radiotherapy concurrent with atezolizumab and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: 3-year follow-up of a multicenter, single-arm, phase 2 trial (MATCH)

低剂量放射治疗与阿替利珠单抗和化疗联合作为广泛期小细胞肺癌的一线治疗方案：一项多中心、单臂、II期试验（MATCH）的3年随访研究

international journal of radiation oncology biology physics

IF0

2025-07-010

Stimulator of Interferon Genes Agonist Synergistically Amplifies Programmed Cell Death Protein-1 Blockade and Radiation-Induced Systemic Antitumor Responses via Tumor Microenvironment Enrichment

干扰素基因刺激因子激动剂通过肿瘤微环境富集，协同增强程序性细胞死亡蛋白-1阻断和辐射诱导的系统抗肿瘤反应。

international journal of radiation oncology biology physics

IF0

2025-04-170

PRE

Congenital pulmonary airway malformation presenting as a solid mass: a description of two cases and a literature analysis

先天性肺气道畸形表现为实性肿块：两例病例描述及文献分析

QUANTITATIVE IMAGING IN MEDICINE AND SURGERY

IF2.3

2024-12-010

Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer

MED

IF11.8

2024-10-013

OAAI

Wang, Hui; Yao, Zhuoran; Kang, Kai; Zhou, Lin; Xiu, Weigang; Sun, Jianguo; Xie, Conghua; Yu, Min; Li, Yanying; Zhang, Yan; Zheng, Yue; Lin, Guo; Pan, Xiangyu; Wu, Yijun; Luo, Ren; Wang, Laduona; Tang, Min; Liao, Shuangsi; Zhu, Jiang; Zhou, Xiaojuan; Zhang, Xuanwei; Xu, Yong; Liu, Yongmei; Peng, Feng; Wang, Jin; Xiang, Lisha; Yin, Limei; Deng, Lei; Huang, Meijuan; Gong, Youling; Zou, Bingwen; Wang, Hui; Wu, Lin; Yuan, Zhiyong; Bi, Nan; Fan, Min; Xu, Yaping; Tong, Ruizhan; Yi, Linglu; Gan, Lu; Xue, Jianxin; Mo, Xianming; Chen, Chong; Na, Feifei; Lu, You

Alectinib Versus Crizotinib in Asian Patients With Treatment-Naïve Advanced ALK-Positive NSCLC : Five-Year Update From the Phase 3 ALESIA Study

JTO CLINICAL AND RESEARCH REPORTS

IF3.5

2024-09-011

PRE

Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR-mutated, advanced non-small cell lung cancer: data from a randomized phase III trial (AENEAS)

未经治疗的EGFR突变的晚期非小细胞肺癌患者中奥罗替尼与吉非替尼的中枢神经系统疗效: 来自随机III期试验 (AENEAS) 的数据

CANCER COMMUNICATIONS

IF24.9

2024-07-170

OAAI

Lu, Shun; Dong, Xiaorong; Jian, Hong; Chen, Jianhua; Chen, Gongyan; Sun, Yuping; Ji, Yinghua; Wang, Ziping; Shi, Jianhua; Lu, Junguo; Chen, Shaoshui; Lv, Dongqing; Zhang, Guojun; Liu, Chunling; Li, Juan; Yu, Xinmin; Lin, Zhong; Yu, Zhuang; Wang, Zhehai; Cui, Jiuwei; Xu, Xingxiang; Fang, Jian; Feng, Jifeng; Xu, Zhi; Ma, Rui; Hu, Jie; Yang, Nong; Zhou, Xiangdong; Wu, Xiaohong; Hu, Chengping; Zhang, Zhihong; Lu, You; Hu, Yanping; Jiang, Liyan; Wang, Qiming; Guo, Renhua; Zhou, Jianying; Li, Baolan; Hu, Chunhong; Tong, Wancheng; Zhang, Helong; Ma, Lin; Chen, Yuan; Jie, Zhijun; Yao, Yu; Zhang, Longzhen; Weng, Jie; Li, Weidong; Xiong, Jianping; Ye, Xianwei; Duan, Jianchun; Yang, Haihua; Sun, Meili; Wei, Hongying; Wei, Jiawei; Zhang, Zheyu; Wu, Qiong

CDK4/6 inhibitor abemaciclib combined with low-dose radiotherapy enhances the anti-tumor immune response to PD-1 blockade by inflaming the tumor microenvironment in Rb-deficient small cell lung cancer

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2024-05-012

OAAI

Immunotherapy for patients with advanced non-small cell lung cancer harboring oncogenic driver alterations other than EGFR : a multicenter real-world analysis

晚期非小细胞肺癌患者的免疫治疗具有非EGFR的致癌驱动改变: 多中心真实世界分析

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2024-04-016

OAAI

Changes of Brain Structure in Patients With Metastatic Non-Small Cell Lung Cancer After Long-Term Target Therapy With EGFR-TKI